Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004067
Status:
COMPLETED
Last Update Posted:
2021-04-29
First Post:
1999-12-10
Brief Title:
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Sponsor:
NSABP Foundation Inc
Organization:
NSABP Foundation Inc
Organization Data
Organization:
NSABP Foundation Inc
Class:
NETWORK
Study ID:
NSABP B-31
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NSABP Foundation Inc
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |